Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Towards Meaningful Engagement for the Patient Voice.

Literature DB >> 31165399

Towards Meaningful Engagement for the Patient Voice.

Peter J Pitts¹.

Abstract

Entities: Species

Year: 2019 PMID： 31165399 DOI： 10.1007/s40271-019-00366-x

Source DB: PubMed Journal: Patient ISSN： 1178-1653 Impact factor: 3.883

× No keyword cloud information.

5 in total

1. Giving Patients' Preferences a Voice in Medical Treatment Life Cycle: The PREFER Public-Private Project.

Authors: Esther W de Bekker-Grob; Conny Berlin; Bennett Levitan; Karim Raza; Kalliopi Christoforidi; Irina Cleemput; Jana Pelouchova; Harald Enzmann; Nigel Cook; Mats G Hansson
Journal: Patient Date: 2017-06 Impact factor: 3.883

2. Giving Patients a Meaningful Voice in United States Regulatory Decision Making: The Role for Health Preference Research.

Authors: F Reed Johnson; Kathleen Beusterien; Semra Özdemir; Leslie Wilson
Journal: Patient Date: 2017-08 Impact factor: 3.883

3. Making Patient Engagement a Reality.

Authors: Daphnee S Pushparajah
Journal: Patient Date: 2018-02 Impact factor: 3.883

4. The FDA guidance for industry on PROs: the point of view of a pharmaceutical company.

Authors: Fabio Arpinelli; Francesco Bamfi
Journal: Health Qual Life Outcomes Date: 2006-10-31 Impact factor: 3.186

5. Enhancing the incorporation of the patient's voice in drug development and evaluation.

Authors: Meghana Chalasani; Pujita Vaidya; Theresa Mullin
Journal: Res Involv Engagem Date: 2018-04-02

5 in total

6 in total

Review 1. Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future.

Authors: Olayinka O Ogunleye; Debashis Basu; Debjani Mueller; Jacqueline Sneddon; R Andrew Seaton; Adesola F Yinka-Ogunleye; Joshua Wamboga; Nenad Miljković; Julius C Mwita; Godfrey Mutashambara Rwegerera; Amos Massele; Okwen Patrick; Loveline Lum Niba; Melaine Nsaikila; Wafaa M Rashed; Mohamed Ali Hussein; Rehab Hegazy; Adefolarin A Amu; Baffour Boaten Boahen-Boaten; Zinhle Matsebula; Prudence Gwebu; Bongani Chirigo; Nongabisa Mkhabela; Tenelisiwe Dlamini; Siphiwe Sithole; Sandile Malaza; Sikhumbuzo Dlamini; Daniel Afriyie; George Awuku Asare; Seth Kwabena Amponsah; Israel Sefah; Margaret Oluka; Anastasia N Guantai; Sylvia A Opanga; Tebello Violet Sarele; Refeletse Keabetsoe Mafisa; Ibrahim Chikowe; Felix Khuluza; Dan Kibuule; Francis Kalemeera; Mwangana Mubita; Joseph Fadare; Laurien Sibomana; Gwendoline Malegwale Ramokgopa; Carmen Whyte; Tshegofatso Maimela; Johannes Hugo; Johanna C Meyer; Natalie Schellack; Enos M Rampamba; Adel Visser; Abubakr Alfadl; Elfatih M Malik; Oliver Ombeva Malande; Aubrey C Kalungia; Chiluba Mwila; Trust Zaranyika; Blessmore Vimbai Chaibva; Ioana D Olaru; Nyasha Masuka; Janney Wale; Lenias Hwenda; Regina Kamoga; Ruaraidh Hill; Corrado Barbui; Tomasz Bochenek; Amanj Kurdi; Stephen Campbell; Antony P Martin; Thuy Nguyen Thi Phuong; Binh Nguyen Thanh; Brian Godman
Journal: Front Pharmacol Date: 2020-09-11 Impact factor: 5.810

Towards Meaningful Engagement for the Patient Voice.

1. Giving Patients' Preferences a Voice in Medical Treatment Life Cycle: The PREFER Public-Private Project.

2. Giving Patients a Meaningful Voice in United States Regulatory Decision Making: The Role for Health Preference Research.

3. Making Patient Engagement a Reality.

4. The FDA guidance for industry on PROs: the point of view of a pharmaceutical company.

5. Enhancing the incorporation of the patient's voice in drug development and evaluation.

Review 1. Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future.

2. Multi-Criteria Decision Analysis for Benefit-Risk Analysis by National Regulatory Authorities.

3. The Patient Perspective: A Matter of Minutes.

4. Patient Perceptions of and Preferences Between Characteristics of Injectable Diabetes Treatments.

5. Our Most Powerful Weapon to Fight COVID-19: Patient Involvement.

6. Dealing with Discontinuity in Cancer Care Trajectories: Patients' Solutions.